Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Willdan Group Q3 2025 Earnings Call - Surging 20% Organic Growth and Expanding Margins Amid Data Center Boom
Willdan Group's Q3 2025 results underscore a powerhouse performance with net revenue soaring 26% year-over-year, fueled by an impressive 20% organic growth. The company continues its streak of four co...
- Q3 2025 net revenue grew 26% year-over-year to $95 million, with a strong 20% organic growth rate driving results.
- Willdan has achieved four consecutive years of double-digit organic growth, reflecting sustained market demand and execution.
- The energy segment comprises 85% of revenue, with 15% from engineering and consulting; data center-related commercial work is a key growth area.
- +12 more takeaways
GEN Digital Q2 FY2026 Earnings Call - Robust Growth Powered by AI Integration and Strategic Expansion of Cybersafety and Financial Wellness
GEN Digital delivered a strong second quarter with revenue surpassing $1.2 billion, marking a 25% year-over-year increase. This growth was driven by broad-based strength across its Norton, Avast, Life...
- GEN Digital reported Q2 revenue of $1.2 billion, up 25% year-over-year, driven by all major brands including Norton, Avast, LifeLock, and MoneyLion.
- The integration of MoneyLion continues smoothly, delivering 50% growth in personal finance products and expanding the financial marketplace by 50% in its engine segment.
- The company operates with strong financial discipline, maintaining a 51% operating margin overall, with 61% in cybersafety and 30% in trust-based solutions.
- +12 more takeaways
Evolent Q3 2025 Earnings Call - Large New Contracts and Margin Discipline Poised for Long-Term Growth
Evolent reported Q3 2025 revenue of $479.5 million, surpassing expectations and continuing strong organic growth through new contracts, particularly in oncology performance management. The company sig...
- Evolent's Q3 2025 revenue hit $479.5 million, at the high end of guidance, reflecting 8% sequential growth driven by new product launches.
- Two new major contracts announced: a Performance Suite oncology deal with a large Blue Cross plan covering 650,000+ members expected to generate $500M+ annually, and a Technology and Services oncology solution with a Southwest provider-sponsored plan.
- The 2026 revenue backlog now stands at approximately $2.5 billion with $750 million in new contracts launching that year, signaling over 30% top-line growth.
- +13 more takeaways
Coherus Oncology Q3 2025 Earnings Call - Strategic Progress Drives LOQTORZI Growth and Pipeline Momentum
Coherus Oncology reported solid Q3 2025 results marked by strong execution on multiple fronts: a 92% year-over-year surge in LOQTORZI revenue, disciplined expense reduction, and a fortified balance sh...
- Coherus Oncology's LOQTORZI sales grew 92% year-over-year to $11.2 million in Q3, driven by new patient starts and longer treatment duration.
- Company targets $150-$200 million peak LOQTORZI revenue by mid-2028, with 10%-15% average demand growth expected over next three years.
- Commercial efforts focus on expanding into community physicians via sales force growth, remote sales teams, and digital education campaigns.
- +7 more takeaways
NuScale Q3 2025 Earnings Call - Landmark 6 GW TVA Agreement Accelerates SMR Commercialization
NuScale reported robust progress in Q3 2025, driven by a historic agreement involving the Tennessee Valley Authority (TVA) and Inter One Energy to deploy up to 6 gigawatts of NuScale's small modular r...
- NuScale secured a landmark agreement with TVA and Inter One Energy to deploy up to 6 GW of SMR nuclear capacity, representing approximately 72 NuScale power modules across up to six plants.
- This 6 GW project is the largest SMR deployment program in U.S. history and could power a metropolitan area the size of Dallas-Fort Worth.
- The agreement includes a milestone partnership agreement (PMA) between NuScale and Inter One, where NuScale advances milestone-based payments to Inter One to accelerate project development and supply chain readiness.
- +7 more takeaways
AMN Healthcare Q3 2025 Earnings Call - Staffing Demand Rebounds, Bill Rates Signal First Rise in Three Years
AMN Healthcare reported a better-than-expected third quarter with $634 million in revenue, beating guidance by $9 million. The recovery from Q2 softness was evident in a moderate rebound in staffing d...
- Q3 revenue reached $634 million, $9 million above guidance, signaling stronger-than-expected demand recovery.
- Adjusted EBITDA was $57.5 million (9.1% margin), 90 basis points above guidance, despite ongoing margin pressures.
- Staffing demand rebounded in Q3 after Q2 softness; travel nurse winter orders slightly favorable compared to prior year.
- +13 more takeaways
StoneCo Q3 2025 Earnings Call - Solid Profit Growth Amid Macro Challenges, Focus Shifts to Credit and Capital Returns
StoneCo's Q3 2025 earnings reveal resilient profit growth despite a challenging macro environment. Adjusted gross profit grew 15.2%, with adjusted basic EPS up 31% year-over-year, reflecting disciplin...
- StoneCo's adjusted gross profit rose 15.2% year-over-year in Q3 2025 despite macroeconomic headwinds.
- Adjusted basic EPS grew 31% year-over-year, reaching BRL 2.57 per share in Q3, maintaining the company on track for its full-year targets.
- The firm returned BRL 2.8 billion to shareholders in the last 12 months via share buybacks, representing about a 10% yield, and has returned 74% of identified excess capital by end-October.
- +12 more takeaways
JFrog Q3 2025 Earnings Call - Cloud Growth and Security Solutions Drive Strong Momentum
JFrog delivered a robust Q3 2025, marked by 26% year-over-year revenue growth to $136.9 million and a 50% surge in cloud revenues reaching $63.4 million. The company’s strategic focus on cloud platfor...
- Q3 2025 total revenue hits $136.9 million, up 26% year-over-year.
- Cloud revenue grows 50% year-over-year to $63.4 million, driven by broader artifact types including AI models.
- Enterprise customers spending over $1 million increased 54% year-over-year to 71 clients.
- +7 more takeaways
Synaptics Q1 FY2026 Earnings Call - Strong IoT Growth and Launch of Next-Gen Astra Edge AI Processors
Synaptics reported a robust start to fiscal 2026, led by a 74% year-over-year surge in core IoT revenues, propelling overall revenue growth of 14%. The highlight of the quarter was the successful laun...
- Synaptics reported Q1 fiscal 2026 revenue of $292.5 million, up 14% year-over-year, exceeding guidance midpoint.
- Core IoT product revenue surged 74% year-over-year, driven by processors and wireless connectivity; it now represents 35% of total revenue.
- Non-GAAP EPS rose 35% year-over-year to $1.09, reflecting strong earnings growth and margin expansion.
- +12 more takeaways
Definitive Healthcare Q3 2025 Earnings Call - Improving Retention and New Logos Amid Revenue Pressure
Definitive Healthcare reported Q3 2025 revenues of $60 million, down 4% year-over-year but at the high end of guidance, with adjusted EBITDA of $18.9 million delivering a strong 32% margin, aided by o...
- Q3 2025 revenue of $60 million declined 4% year-over-year but was at the high end of guidance.
- Adjusted EBITDA was $18.9 million with a 32% margin, above guidance, reflecting operational improvements and cost discipline.
- Total customer count held steady at ~2,400 while enterprise customers increased by 10 to 520, the highest since Q3 2024.
- +11 more takeaways